Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics
Bibliographic Data
| ID | 15529263 |
|---|---|
| Authors | James Sexton (0000-0002-4082-195X, University of Alabama at Birmingham), Charles D Nichols (0000-0002-0615-0646, Louisiana State University Health Sciences Center New Orleans), Peter S Hendricks (University of Alabama at Birmingham, corresponding author) |
| Year | 2020 |
| Volume | 10 |
| Pages | 896-896 |
| Publication date | 2020-02-11 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2019.00896 |
| PMID | 32116806 |
| OpenAlex | W3006069447 |
| Language | EN |
| Citations received | 10 |
| References cited | 13 |
These findings, which may be driven by differences in pharmacodynamics, suggest that classic tryptamines may hold the greatest therapeutic potential of the psychedelics, whereas novel phenethylamines may pose risk for harm. The present findings thus support continued research on the clinical application of classic tryptamines. Though the current results caution against the clinical utility of novel phenethylamines, further study of these and other novel psychedelic substances is nonetheless warranted to better understand their potential application
Environmental health · Hallucinogen · Phenethylamine · Population · Psilocybin · Psychiatry · Psychotherapist · Tryptamine · Chemical synthesis and alkaloids · Medicine · Neurotransmitter Receptor Influence on Behavior · Psychedelics and Drug Studies · Psychology · Pharmacology
Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use
Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests
Psychedelic Mushrooms in the USA
Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being
The association between naturalistic use of psychedelics and co-occurring substance use disorders
Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States
Naturalistic Psychedelic Use
Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems
Factors associated with psychedelic attitudes and usage among college students
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Classic psychedelics
Emotional breakthrough and psychedelics
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
The Challenging Experience Questionnaire
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression
Psilocybin with psychological support for treatment-resistant depression
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Short screening scales to monitor population prevalences and trends in non-specific psychological distress
Psychoactive Substances in Prehistoric Times
Results of an international drug testing service for cryptomarket users
My Friend Said it was Good LSD”
| Unique citing works | 10 |
|---|---|
| Citations per year | 2,5 |
| Citation span | 2022 - 2025 (4) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 10 |